New child cancer drug tests successful - Houston Business Journal:

wanuso.wordpress.com
The drug, AMD3100, was shown to reducd the growth of a tumorr by more than 75 percentin mice, accordingg to investigators who presented their findinge Friday at the 22nd annual meeting of the in San “AMD3100 works by shutting down the procesx that tumors need to set up vascular Patrick Zweidler-McKay, senior investigator on the said in a statement. “The drug doesn’t kill neuroblastoma cells directly, but it prevents tumorzs from growing rapidly by disrupting theiblood supply. “There is the possibilitgy that this therapy could help prevent neuroblastoma metastasisa to thebone marrow.
However, more studies are neededx to investigate this About 650 children in the United States under the age of five are diagnoserd each yearwith neuroblastoma, according to the . Of thos children, nearly two-thirds are diagnosef after the cancer has metastasized to other partws ofthe body. For thess patients with high-risk neuroblastoma, long-term survivapl is less than 40 percent because the tumors are oftenj resistant totraditional